Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
about
Nutrition and Hepatocellular CancerThe Natural Course of Non-Alcoholic Fatty Liver DiseaseVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinHepatocellular carcinoma and non-alcoholic steatohepatitis: The state of playBiomarker-Based Approaches for Assessing Alcohol Use DisordersNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistancePathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenThe necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.Exploring the metabolic syndrome: Nonalcoholic fatty pancreas diseaseDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewSleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy ControlsLow vitamin D status and obesity: Role of nutritionist.Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease.Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease.Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis.Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markersEffect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.Independent tissue contributors to obesity-associated insulin resistance.Pancreatic steatosis: Is it related to either obesity or diabetes mellitus?Genome-wide blood DNA methylation alterations at regulatory elements and heterochromatic regions in monozygotic twins discordant for obesity and liver fat.Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver diseaseNon-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3aAssociation of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study.Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective StudiesInfluence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese populationThe role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver DiseaseProlyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study
P2860
Q26741102-C8BFECAC-6DC7-46A5-99A8-41C69773CC1FQ26746947-ADD95663-2745-4CCC-A64E-3E363956E322Q26750865-90EC14AD-EF79-4240-B895-EC85172342D6Q26764911-20431F8D-0487-4D3E-A02E-76DC60CF15F6Q26772931-751B7F05-C221-4B15-BAA7-CE8A690152F5Q26778135-687E63B6-A845-41E0-A52D-C0D030165B6CQ26861095-755F1199-5695-4D76-A7DA-B875C7EE996CQ27313354-1EB54964-DDFE-495A-BF8A-D660A5887916Q28069643-C3DEEC4F-AE43-4DD6-B92A-21755FCE2DA8Q28070408-E94FA011-8B34-4F7B-9DAF-D8F00EAA158FQ28551009-8ACAF64F-EF62-4B14-9826-FD186AB4CF8FQ30235602-FE470DCC-A4CF-459D-A0FF-578FB0AF3012Q30251565-24AA03B6-C5B9-4403-A5A9-45D037F95321Q30430392-5D1FCCB0-2E9C-4745-9267-2119B38590EEQ30991322-4C754D45-58F3-4002-A25C-220AC9168366Q31171499-41DA724A-3D79-4872-A98D-9BE25B5B8652Q33586821-17D00EC9-C2BC-4CBA-8DE6-D60786718840Q33631151-1CC1640F-5979-46D9-818E-05592514450DQ33751826-49B4C8FD-FA0B-4C72-9D42-8206D175E09DQ33811776-6C392981-7172-42EA-A34E-D70DDD195B46Q33822990-EDD2010E-C50E-4C8C-9776-12C3C186F41AQ33858997-1F4E32E2-E0FE-4112-8BBF-5CA35316749CQ33877805-D7A448DD-CB53-4424-9AD3-340867D4E923Q34023530-706BEE35-3F60-45DC-ADF0-EA1F35F483C6Q35368842-82DAE832-797A-44A8-B621-C1B047AFDE54Q35527594-18CD6673-F76E-48C1-A4E2-D70060DA8863Q35573353-3C2E9CF4-4C12-41AA-BC69-328A465DE362Q35841934-938D40EE-BBCA-4DCB-800E-671DC214054EQ35878960-8C80D56F-0F51-4D9A-A3C1-B1F1754846E6Q35914994-2A5D5FBF-3E38-489D-9707-C5D474C85EB9Q35926253-638A9AB1-DCA9-429A-A5A4-63969CB3B4E1Q36099467-B2818049-E783-48DB-A8A7-9874D0F11408Q36118420-76439074-16BA-46BD-B6CE-86691639616DQ36120514-E82AF11B-46BF-4611-B37D-2D33BD31BCB2Q36123336-ACC13263-D30B-482F-AD60-CFC3637AAE73Q36126574-864892C8-730D-423F-AB13-59F60A1CFCE8Q36167936-83EA4591-4831-4D35-BD1E-AF15C6FA75BFQ36325487-6EC754FF-48EA-480D-8059-9F1F184DD45BQ36329899-A31571D1-79EA-4CD5-833F-5189B98D01DFQ36572295-EEAC40AD-BF94-448F-8F64-986388212F74
P2860
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
@en
type
label
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
@en
prefLabel
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
@en
P1476
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
@en
P304
P356
10.1016/S2213-8587(14)70032-4
P577
2014-04-07T00:00:00Z